The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Sage Therapeutics, Inc(NASDAQ:SAGE) 
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product p...
Website: http://www.sagerx.com
Founded: 2010
Full Time Employees: 675
Sector: Healthcare
Industry: Biotechnology
Sage Therapeutics Days Payable Outstanding ttm (DPO)
Sage Therapeutics Days Receivable Outstanding ttm (DSO)
Sage Therapeutics Days Inventory Outstanding ttm (DIO)
Sage Therapeutics Op Cashflow Per Share ttm
Sage Therapeutics Free Cashflow Per Share ttm
Sage Therapeutics Cash Per Share ttm
Sage Therapeutics P/S ratio ttm
Sage Therapeutics (GAAP) P/E ratio ttm
Sage Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.